Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer

NCT04464226 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

402

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer

Interventions

DRUG: Darolutamide (Nubeqa, BAY1841788)

Sponsor

Bayer